5-amino-1mq and cd38 inhibitor synergy nad+ Heavy-chain antibody targeting of hydrolase ectoenzyme to prevent fibrosis in multiple organs Dysregulation of Niacin-Derived NAD+ Salvage
Dysregulation of Niacin Derived NAD+ Salvage Pathway Markers (CD38, NAMPT, SIRT1) Across Albuminuria Stages in Type 2 Diabetes A Potent and Specific CD38 Inhibitor Ameliorates Age Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline ScienceDirect Targeting CD38 dependent NAD+ metabolism to mitigate multiple organ fibrosis ScienceDirect Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice Scientific Reports Nicotinamide N Methyltransferase in Cardiovascular Diseases: Metabolic Regulator and Emerging Therapeutic Target
Pay in 4 interest-free payments of $6.03 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9




